19.25 -0.48 (-2.41%)
PRXL
Stock Details
Last Trade:19.25 Change:-0.48 (-2.41%) Prev Close:19.73 Open: 19.90 Days Range:19.16 – 19.96 52 Week Range: 7.20 - 21.10 Volume:750609 P/E: 30.56EPS:0.63
View AllRecent Alerts 02/09/10
Recent Alert on 01/26/10 at 12:30pm
Unusual 11 Mid-Day Movers 1/26: VCBI, DEAR, TSCM, PLXT, VLTR Higher; CBPO, MLP, SMTX, GASS Lower
Unusual 11 Mid-Day Movers 1/26: VCBI, DEAR, TSCM, PLXT, VLTR Higher; CBPO, MLP, SMTX, GASS Lower
Virginia Commerce Bancorp, Inc. (Nasdaq: VCBI) 36.7% HIGHER; reports Q4 EPS of $0.11, compared to $0.04 in the same quarter last year. The stock was also upgraded to Outperform at Raymond James. Dearborn Bancorp (Nasdaq: DEAR) 35.8% HIGHER; crazy... Read More
Recent Alert on 01/25/10 at 5:45pm
After-Hours Movers 1/25: THLD, VMW, MTXX, PLXT, PRXL Higher; ZRAN, CVO, ATHR, TXN, AAPL Lower
After-Hours Movers 1/25: THLD, VMW, MTXX, PLXT, PRXL Higher; ZRAN, CVO, ATHR, TXN, AAPL Lower
Recent Alert on 01/25/10 at 5:00pm
Parexel (PRXL) Posts Q2 adj.-EPS of $0.26, Tops by 4c; Raises FY10 and Q310 Guidance Above Street
Parexel (PRXL) Posts Q2 adj.-EPS of $0.26, Tops by 4c; Raises FY10 and Q310 Guidance Above Street
Recent Alert on 01/25/10 at 5:00pm
Parexel (PRXL) Posts Q2 adj.-EPS of $0.26, Tops by 4c; Raises FY10 and Q310 Guidance Above Street
Parexel (PRXL) Posts Q2 adj.-EPS of $0.26, Tops by 4c; Raises FY10 and Q310 Guidance Above Street
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
SEC Filing on 02/09/10 at 9:31am
Form 4 PAREXEL INTERNATIONAL For: Feb 08 Filed by: LINDOP CHRISTOPHER J
Form 4 PAREXEL INTERNATIONAL For: Feb 08 Filed by: LINDOP CHRISTOPHER J
View AllRecent Blog Posts
Blog Posts on 01/26/10 at 2:29pm
PAREXEL International Corporation F2Q10 (Qtr End 12/31/09) Earnings Call Transcript
PAREXEL International Corporation F2Q10 (Qtr End 12/31/09) Earnings Call Transcript
Blog Posts on 08/11/09 at 4:11pm
PAREXEL International Corp. F4Q09 (Qtr End 06/30/09) Earnings Call Transcript
PAREXEL International Corp. F4Q09 (Qtr End 06/30/09) Earnings Call Transcript
Blog Posts on 07/29/09 at 11:07am
Ariad Pharmaceuticals: Advancing in Front of Phase 3 Interim Results
Ariad Pharmaceuticals: Advancing in Front of Phase 3 Interim Results